Toyosi Onwuemene/LinkedIn
Jun 16, 2026, 13:06
Toyosi Onwuemene: Why Anticoagulation Errors Persist Despite Strong Protocols
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a post on LinkedIn:
“A community health system pharmacist told me she reviews up to 10 anticoagulation-related safety events each week.
Not near misses.
Reportable events.
Her health system takes safety seriously.
- They build more protocols.
- They create more guidelines.
- They add more EHR hard stops.
Yet the events keep happening.
Because anticoagulation errors often occur outside the guidelines:
- The patient with bleeding and clotting risk.
- The peri‑procedural hold for an urgent procedure.
- The renal function that declined overnight.
Guidelines are built for standard cases.
Clinicians struggle with the exceptions.
Anticoagulation safety depends on how well your system supports clinicians when the case falls outside the protocol.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?